🚀 VC round data is live in beta, check it out!
Wellgistics Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Wellgistics Health and similar public comparables like Lifecare, Arcoma, Trinity Biotech, Bionano Genomics and more.
Wellgistics Health Overview
About Wellgistics Health
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Founded
2022
HQ
Employees
13
Website
Financials (FY)
EV
$38M
Wellgistics Health Financials
Wellgistics Health reported last fiscal year revenue of $23M and negative EBITDA of ($93M).
In the same fiscal year, Wellgistics Health generated ($6M) in gross profit, ($93M) in EBITDA losses, and had net loss of ($101M).
Wellgistics Health P&L
In the most recent fiscal year, Wellgistics Health reported revenue of $23M and EBITDA of ($93M).
Wellgistics Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $23M | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($6M) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (28%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($93M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (401%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (348%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($101M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (434%) | XXX | XXX | XXX |
| Net Debt | — | — | $24M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Wellgistics Health Stock Performance
Wellgistics Health has current market cap of $13M, and enterprise value of $38M.
Market Cap Evolution
Wellgistics Health's stock price is $0.11.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $38M | $13M | -14.2% | XXX | XXX | XXX | $-0.84 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialWellgistics Health Valuation Multiples
Wellgistics Health trades at 1.6x EV/Revenue multiple, and (0.4x) EV/EBITDA.
Wellgistics Health Financial Valuation Multiples
As of April 10, 2026, Wellgistics Health has market cap of $13M and EV of $38M.
Equity research analysts estimate Wellgistics Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Wellgistics Health has a P/E ratio of (0.1x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $13M | XXX | $13M | XXX | XXX | XXX |
| EV (current) | $38M | XXX | $38M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.6x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (0.4x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (0.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (5.9x) | XXX | XXX | XXX |
| P/E | — | XXX | (0.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (3.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Wellgistics Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Wellgistics Health Margins & Growth Rates
Wellgistics Health's revenue in the last fiscal year grew by 29%.
Wellgistics Health's revenue per employee in the last FY averaged $1.8M, while opex per employee averaged $5.8M for the same period.
Wellgistics Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (401%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 1804% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.8M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $5.8M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 301% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 320% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Wellgistics Health Public Comps
See public comps and valuation multiples for other Medical Devices and Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lifecare | XXX | XXX | XXX | XXX | XXX | XXX |
| Arcoma | XXX | XXX | XXX | XXX | XXX | XXX |
| Trinity Biotech | XXX | XXX | XXX | XXX | XXX | XXX |
| Bionano Genomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Pilulka Lekarny | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Wellgistics Health M&A Activity
Wellgistics Health acquired XXX companies to date.
Last acquisition by Wellgistics Health was on XXXXXXXX, XXXXX. Wellgistics Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Wellgistics Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialWellgistics Health Investment Activity
Wellgistics Health invested in XXX companies to date.
Wellgistics Health made its latest investment on XXXXXXXX, XXXXX. Wellgistics Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Wellgistics Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Wellgistics Health
| When was Wellgistics Health founded? | Wellgistics Health was founded in 2022. |
| Where is Wellgistics Health headquartered? | Wellgistics Health is headquartered in United States. |
| How many employees does Wellgistics Health have? | As of today, Wellgistics Health has over 13 employees. |
| Is Wellgistics Health publicly listed? | Yes, Wellgistics Health is a public company listed on Nasdaq. |
| What is the stock symbol of Wellgistics Health? | Wellgistics Health trades under WGRX ticker. |
| When did Wellgistics Health go public? | Wellgistics Health went public in 2025. |
| Who are competitors of Wellgistics Health? | Wellgistics Health main competitors are Lifecare, Arcoma, Trinity Biotech, Bionano Genomics. |
| What is the current market cap of Wellgistics Health? | Wellgistics Health's current market cap is $13M. |
| What is the current revenue of Wellgistics Health? | Wellgistics Health's last fiscal year revenue is $23M. |
| What is the current EV/Revenue multiple of Wellgistics Health? | Current revenue multiple of Wellgistics Health is 1.6x. |
| Is Wellgistics Health profitable? | No, Wellgistics Health is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.